Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | -6.70% | -32.29% | -65.97% |
Jun. 04 | US Equities Markets Close Mixed Monday as US Manufacturing Contracts | MT |
Jun. 04 | HC Wainwright Adjusts Price Target on Caribou Biosciences to $9 From $24, Maintains Buy Rating | MT |
Business Summary
Number of employees: 158
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Allogeneic CAR-T and CAR-NK Cell Therapies
100.0
%
| 14 | 100.0 % | 34 | 100.0 % | +148.91% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
95.0
%
| 13 | 96.0 % | 33 | 95.0 % | +146.34% |
Rest of World
5.0
%
| 1 | 4.0 % | 2 | 5.0 % | +211.50% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rachel Haurwitz
FOU | Founder | 37 | 11-10-27 |
Jason O’Byrne
DFI | Director of Finance/CFO | 55 | 21-02-08 |
Steven Kanner
CTO | Chief Tech/Sci/R&D Officer | 65 | 17-05-31 |
Timothy Kelly
CTO | Chief Tech/Sci/R&D Officer | 55 | Jan. 06 |
Reigin Zawadzki
HRO | Human Resources Officer | - | 23-09-26 |
Cindy Hayashi
HRO | Human Resources Officer | - | 16-07-31 |
Ryan Fischesser
AUD | Comptroller/Controller/Auditor | - | - |
Elaine Alambra
LAW | General Counsel | - | - |
Ruhi Khan
PRN | Corporate Officer/Principal | 49 | 21-11-07 |
Barbara McClung
LAW | General Counsel | 69 | 15-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 55 | 21-03-31 | |
Scott Braunstein
BRD | Director/Board Member | 60 | 21-05-31 |
Director/Board Member | 60 | 21-11-07 | |
Rachel Haurwitz
FOU | Founder | 37 | 11-10-27 |
Natalie Sacks
BRD | Director/Board Member | 59 | 18-04-30 |
David Johnson
BRD | Director/Board Member | 55 | 22-05-10 |
Ran Zheng
BRD | Director/Board Member | 61 | 21-09-23 |
Nancy Whiting
BRD | Director/Board Member | 51 | 21-08-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 90,317,771 | 81,234,137 ( 89.94 %) | 0 | 89.94 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.97% | 176M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CRBU Stock
- Company Caribou Biosciences, Inc.